Glycine and D-serine decrease MK-801-induced hyperactivity in mice

Journal of Neural Transmission

Volumn 104, Issue 11-12, 1997, Pages 1195-1205

  Nilsson, M ^a   Carlsson, A ^a   Carlsson, M L ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

D serine; Glycine; ICV; Locomotion; MK 801; Mouse

Indexed keywords

DIZOCILPINE; GLYCINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; SERINE;

ANIMAL EXPERIMENT; ARTICLE; HYPERACTIVITY; MALE; MOUSE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; GLYCINE; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; MOTOR ACTIVITY; RECEPTORS, N-METHYL-D-ASPARTATE; SERINE; SYNAPTIC TRANSMISSION;

EID: 0031435415     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01294720     Document Type: Article

References (33)

1. 3H]strychnine binding sites in rat brain. Eur J Pharmacol 126: 303-307
2. Carlsson A (1988) The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1: 179-186
3. Carlsson A (1992) Neurotransmitter dysfunction in schizophrenia. Proceedings, 7th International Symposium of the Tokyo Institute of Psychiatry, October 19-20 Tokyo, Japan, pp 167-183
4. Carlsson M, Carlsson A (1990) Interactions between glutamatergic and monoaminergic systems within the basal ganglia - implications for schizophrenia and Parkinson's disease. TINS 13: 272-276
5. Chouinard ML, Gaitan D, Wood PL (1993) Presence of the N-methyl-d-aspartate-associated glycine receptor agonist, d-serine, in human temporal cortex: comparison of normal, Parkinson, and Alzheimer tissues. J Neurochem 61: 1561-1564
6. Contreras PC (1990) D-serine antagonized phencyclidine- and MK-801-induced stereotyped behaviour and ataxia. Neuropharmacology 29: 291-293
7. Cuzick J (1985) A Wilcoxon-type test for trend. Stat Med 4: 87-90
8. Garland Bunney B, Bunney WE Jr, Carlsson A (1995) Psychopharmacology: the fourth generation of progress. Raven Press, New York, pp 1205-1214
9. Hashimoto A, Oka T, Nishikawa T (1995) Extracellular concentration of endogenous free d-serine in the rat brain as revealed by in vivo microdialysis. Neurosci 66: 635-643
10. Javitt DC (1987) Negative schizophrenic symptomatology and PCP (phencyclidine) model of schizophrenia. Hillside J Clin Psych 9: 12-33
11. Kim JS, Kornhuber HH, Schmid-Burgk W, Holzmuller B (1980) Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neurosci Lett 20: 379-382
12. Lahti AC, Koffel B, LaPorte D, Tamminga CA (1995) Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology 13: 9-19
13. Lehmann J, Colpaert F, Canton H (1991) Clutamate and glycine co-activate while polyamines merely modulate the NMDA receptor complex. Prog Neuropsychopharmacol Biol Psychiatry 15: 183-190
14. Lodge D, Johnson KM (1990) Noncompetitive excitatory amino acid receptor antagonists. TIPS 11: 81-86
15. MacDonald JF, Nowak LM (1990) Mechanisms of blockade of excitatory amino acid receptor channels. TIPS 11: 167-172
16. McBain CJ, Kleckner NW, Wyrick S, Dingledine R (1989) Structural requirements for activation of the glycine coagonist site of N-methyl-D-aspartate receptors expressed in xenopus oocytes. Mol Pharmacol 36: 556-565
17. 3H]glycine binding sites in rat brain by quantitative receptor autoradiography. Neurosci 35: 653-668
18. Nilsson M, Carlsson ML (1997) The glycine antagonist (+)-HA-966 injected into the nucleus accumbens stimulates locomotion in mice. J Neural Transm 104: 419-425
19. Patel J, Zinkand WC, Thompson C, Keith R, Salama A (1990) Role of glycine in the N-methyl-D-aspartate-mediated neuronal cytotoxicity. J Neurochem 54: 849-854
20. Pullan LM, Powel RJ (1992) Comparison of binding at strychnine-sensitive (inhibitory glycine receptor) and strychnine-insensitive (N-methyl-D-aspartate receptor) glycine binding sites. Neurosci Lett 148: 199-201
21. Rao TS, Cler JA, Emmett MR, Mick SJ (1990) Glycine, glycinamide and D-serine act as positive modulators of signal transduction at the N-methyl-D-aspartate (NMDA) receptor in vivo: differential effects on mouse cerebellar cyclic guanosine monophosphate levels. Neuropharmacology 29: 1075-1080
22. Reynolds IJ, Miller RJ (1988) Multiple sites for the regulation of the N-methyl-D-aspartate receptor. Mol Pharmacol 33: 581-584
23. Salt TE (1989) Modulation of NMDA receptor-mediated responses by glycine and d-serine in the rat thalamus in vivo. Brain Res 481: 403-406
24. Schell MJ, Molliver ME, Snyder SH (1995) D-serine, an endogenous synaptic modulator: localization to astrocytes and glutamate-stimulated release. Proc Natl Acad Sci USA 92: 3948-3952
25. Singh L, Oles RJ, Tricklebank MD (1990) Modulation of seizure susceptibility in the mouse by the strychnine-insensitive glycine recognition site of the NMDA receptor/ ion channel complex. Br J Pharmacol 99: 285-288
26. Tanii Y, Nishikawa T, Hashimoto A, Takahashi K (1994) Stereoselective antagonism by enantiomers of alanine and serine of phencyclidine-induced hyperactivity, stereotypy and ataxia in the rat. J Pharmacol Exp Ther 269: 1040-1048
27. Thomson AM (1990) Glycine is a coagonist at the NMDA receptor/channel complex. Prog Neurobiol 35: 53-74
28. Toth E, Lajtha A (1986) Antagonism of phencyclidine-induced hyperactivity by glycine in mice. Neurochem Res 11: 393-400
29. White WF, Brown KL, Frank DM (1989) Glycine binding to rat cortex and spinal cord: binding characteristics and pharmacology reveal distinct populations of sites. J Neurochem 53: 503-512
30. Wong EHF, Kemp JA (1991) Sites for antagonism on the N-methyl-D-aspartate receptor channel complex. Ann Rev Pharmacol Toxicol 31: 401-125
31. Wong EHF, Kemp JA, Priestley T, Knight AR, Woodruff GN, Iversen LL (1986) The anticonvulsant MK-801 is a potent N-methyl-D-asparlate antagonist. Proc Natl Acad Sci USA 83: 7104-7108
32. Wood PL (1995) The co-agonist concept: is the NMDA-associated glycine receptor saturated in vivo? Life Sci 57: 301-310
33. Wood PL, Emmett MR, Rao TS, Micks S, Cler J, Iyengar S (1989) In vivo modulation of the NMDA receptor complex by d-serine. Potentiation of on-going neuronal activity as evidenced by increased cerebellar cGMP. J Neurochem 53: 979-981